Wealth Enhancement Advisory Services, LLC Eli Lilly & CO Transaction History

Wealth Enhancement Advisory Services, LLC

$44.5 Billion
Q3 2024

A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 167,718 shares of LLY stock, worth $133 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares

167,718

Previous 157,053 6.79%

Holding current value

$133 Million

Previous $142 Million 4.5%

% of portfolio

0.33%

Previous 0.35%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	BUY	$772.14 - $960.02 $8.23 Million - $10.2 Million	10,665 Added 6.79%	167,718 $149 Million
Q2 2024 Jul 16, 2024	BUY	$724.87 - $909.04 $16.4 Million - $20.5 Million	22,603 Added 16.81%	157,053 $142 Million
Q1 2024 Apr 15, 2024	BUY	$592.2 - $792.28 $6.4 Million - $8.56 Million	10,800 Added 8.73%	134,450 $105 Million
Q4 2023 Jan 30, 2024	BUY	$525.19 - $619.13 $2.39 Million - $2.82 Million	4,549 Added 3.82%	123,650 $72.1 Million
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $34.8 Million - $47.9 Million	79,986 Added 204.49%	119,101 $64 Million
Q2 2023 Jul 21, 2023	SELL	$350.74 - $468.98 $1.37 Million - $1.83 Million	-3,911 Reduced 9.09%	39,115 $18.3 Million
Q1 2023 Apr 25, 2023	BUY	$310.63 - $364.82 $3.01 Million - $3.54 Million	9,706 Added 29.13%	43,026 $14.8 Million
Q4 2022 Feb 01, 2023	BUY	$321.55 - $374.67 $8.19 Million - $9.54 Million	25,457 Added 323.76%	33,320 $12.2 Million
Q3 2022 Oct 17, 2022	SELL	$296.48 - $337.87 $2.59 Million - $2.96 Million	-8,751 Reduced 52.67%	7,863 $2.57 Million
Q2 2022 Jul 18, 2022	BUY	$278.73 - $327.27 $4.63 Million - $5.44 Million	16,614 New	16,614 $5.49 Million
Q4 2021 Feb 08, 2022	SELL	$224.85 - $279.04 $5.12 Million - $6.35 Million	-22,750 Closed	0 $0
Q3 2021 Nov 03, 2021	SELL	$221.6 - $272.71 $2.98 Million - $3.66 Million	-13,435 Reduced 37.13%	22,750 $5.65 Million
Q2 2021 Aug 10, 2021	SELL	$180.55 - $233.54 $2.79 Million - $3.6 Million	-15,426 Reduced 29.89%	36,185 $8.38 Million
Q1 2021 May 12, 2021	BUY	$164.32 - $212.72 $207,536 - $268,665	1,263 Added 2.51%	51,611 $9.43 Million
Q4 2020 Feb 10, 2021	BUY	$130.46 - $172.63 $2.43 Million - $3.22 Million	18,640 Added 58.79%	50,348 $9.61 Million
Q3 2020 Nov 12, 2020	BUY	$146.22 - $169.13 $3.31 Million - $3.83 Million	22,622 Added 248.98%	31,708 $4.9 Million
Q2 2020 Oct 13, 2020	BUY	$136.42 - $164.18 $1.24 Million - $1.49 Million	9,086 New	9,086 $1.5 Million
Q2 2020 Aug 10, 2020	SELL	$136.42 - $164.18 $4.96 Million - $5.96 Million	-36,330 Closed	0 $0
Q1 2020 May 01, 2020	BUY	$119.05 - $147.35 $645,370 - $798,784	5,421 Added 17.54%	36,330 $5.72 Million
Q4 2019 Feb 05, 2020	BUY	$106.92 - $132.43 $3.3 Million - $4.09 Million	30,909 New	30,909 $4.06 Million
Q3 2019 Nov 06, 2019	SELL	$106.79 - $116.16 $3.12 Million - $3.39 Million	-29,178 Closed	0 $0
Q2 2019 Aug 02, 2019	BUY	$110.79 - $129.32 $1.82 Million - $2.12 Million	16,428 Added 128.85%	29,178 $3.17 Million
Q1 2019 Apr 30, 2019	SELL	$111.31 - $131.02 $352,518 - $414,940	-3,167 Reduced 19.9%	12,750 $1.5 Million
Q4 2018 Feb 04, 2019	BUY	$105.9 - $118.64 $1.69 Million - $1.89 Million	15,917 New	15,917 $1.86 Million
Q4 2017 Jan 19, 2018	SELL	$81.94 - $87.89 $874,299 - $937,786	-10,670 Closed	0 $0
Q3 2017 Oct 18, 2017	BUY	$77.07 - $85.54 $822,336 - $912,711	10,670	10,670 $929,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Enhancement Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Enhancement Advisory Services, LLC with notifications on news.

Account

Wealth Enhancement Advisory Services, LLC Eli Lilly & CO Transaction History